Treatment periods | Follow up periods | |||||
---|---|---|---|---|---|---|
No treatment group (n = 17) | Treatment group (n = 19) | P value | No treatment group (n = 12) | Treatment group (n = 16) | P value | |
Leukocytosis | 1/17 (5.9%) | 1/19 (5.3%) | 1.0a | 1/12 (8.3%) | 0/16 (0) | 0.429a |
Increase in aminotransferases | 4/17 (23.5%) | 11/19 (57.9%) | 0.037 | 6/12 (50.0%) | 4/16 (25.0%) | 0.333b |
Increase in bilirubin | 6/17 (35.3%) | 2/19 (10.5%) | 0.167b | 4/12 (33.3%) | 0/16 (0) | 0.051b |